nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—psoriatic arthritis	0.907	1	CbGaD
Rescinnamine—Gingivitis—Auranofin—psoriatic arthritis	0.00285	0.0307	CcSEcCtD
Rescinnamine—Rosacea—Prednisone—psoriatic arthritis	0.00238	0.0255	CcSEcCtD
Rescinnamine—Hypertrichosis—Triamcinolone—psoriatic arthritis	0.00173	0.0186	CcSEcCtD
Rescinnamine—Hypertrichosis—Methylprednisolone—psoriatic arthritis	0.00172	0.0185	CcSEcCtD
Rescinnamine—Hypertrichosis—Betamethasone—psoriatic arthritis	0.00157	0.0168	CcSEcCtD
Rescinnamine—Hypertrichosis—Dexamethasone—psoriatic arthritis	0.00157	0.0168	CcSEcCtD
Rescinnamine—Pigmentation disorder—Prednisone—psoriatic arthritis	0.00155	0.0167	CcSEcCtD
Rescinnamine—Sunburn—Methotrexate—psoriatic arthritis	0.00144	0.0154	CcSEcCtD
Rescinnamine—Hypertrichosis—Prednisone—psoriatic arthritis	0.00136	0.0147	CcSEcCtD
Rescinnamine—Taste metallic—Methotrexate—psoriatic arthritis	0.00136	0.0147	CcSEcCtD
Rescinnamine—Osteoporosis—Prednisolone—psoriatic arthritis	0.00127	0.0137	CcSEcCtD
Rescinnamine—Conjunctivitis—Auranofin—psoriatic arthritis	0.00122	0.0131	CcSEcCtD
Rescinnamine—Osteoporosis—Triamcinolone—psoriatic arthritis	0.00117	0.0126	CcSEcCtD
Rescinnamine—Osteoporosis—Methylprednisolone—psoriatic arthritis	0.00117	0.0126	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Triamcinolone—psoriatic arthritis	0.0011	0.0119	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Methylprednisolone—psoriatic arthritis	0.0011	0.0118	CcSEcCtD
Rescinnamine—Osteoporosis—Dexamethasone—psoriatic arthritis	0.00106	0.0114	CcSEcCtD
Rescinnamine—Osteoporosis—Betamethasone—psoriatic arthritis	0.00106	0.0114	CcSEcCtD
Rescinnamine—Tooth disorder—Triamcinolone—psoriatic arthritis	0.00101	0.0109	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Dexamethasone—psoriatic arthritis	0.001	0.0108	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Betamethasone—psoriatic arthritis	0.001	0.0108	CcSEcCtD
Rescinnamine—Dysgeusia—Auranofin—psoriatic arthritis	0.000958	0.0103	CcSEcCtD
Rescinnamine—Osteoporosis—Prednisone—psoriatic arthritis	0.000925	0.00994	CcSEcCtD
Rescinnamine—Abscess—Prednisolone—psoriatic arthritis	0.000902	0.0097	CcSEcCtD
Rescinnamine—Stinging—Prednisolone—psoriatic arthritis	0.000881	0.00947	CcSEcCtD
Rescinnamine—Eye irritation—Prednisolone—psoriatic arthritis	0.000836	0.00898	CcSEcCtD
Rescinnamine—Abscess—Triamcinolone—psoriatic arthritis	0.00083	0.00892	CcSEcCtD
Rescinnamine—Abscess—Methylprednisolone—psoriatic arthritis	0.000828	0.0089	CcSEcCtD
Rescinnamine—Tingling sensation—Methylprednisolone—psoriatic arthritis	0.000815	0.00876	CcSEcCtD
Rescinnamine—Stinging—Triamcinolone—psoriatic arthritis	0.00081	0.00871	CcSEcCtD
Rescinnamine—Hypothyroidism—Prednisone—psoriatic arthritis	0.000808	0.00868	CcSEcCtD
Rescinnamine—Osteoporosis—Methotrexate—psoriatic arthritis	0.000773	0.00831	CcSEcCtD
Rescinnamine—Abscess—Dexamethasone—psoriatic arthritis	0.000753	0.00809	CcSEcCtD
Rescinnamine—Abscess—Betamethasone—psoriatic arthritis	0.000753	0.00809	CcSEcCtD
Rescinnamine—Tingling sensation—Betamethasone—psoriatic arthritis	0.000741	0.00796	CcSEcCtD
Rescinnamine—Tingling sensation—Dexamethasone—psoriatic arthritis	0.000741	0.00796	CcSEcCtD
Rescinnamine—Stinging—Betamethasone—psoriatic arthritis	0.000735	0.0079	CcSEcCtD
Rescinnamine—Stinging—Dexamethasone—psoriatic arthritis	0.000735	0.0079	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Methotrexate—psoriatic arthritis	0.000729	0.00783	CcSEcCtD
Rescinnamine—Cough increased—Triamcinolone—psoriatic arthritis	0.000717	0.00771	CcSEcCtD
Rescinnamine—Psoriasis—Methotrexate—psoriatic arthritis	0.00069	0.00741	CcSEcCtD
Rescinnamine—Constipation—Auranofin—psoriatic arthritis	0.000683	0.00734	CcSEcCtD
Rescinnamine—Abscess—Prednisone—psoriatic arthritis	0.000656	0.00705	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000653	0.00702	CcSEcCtD
Rescinnamine—Dermatitis contact—Triamcinolone—psoriatic arthritis	0.000649	0.00697	CcSEcCtD
Rescinnamine—Urticaria—Auranofin—psoriatic arthritis	0.000634	0.00682	CcSEcCtD
Rescinnamine—Abdominal pain—Auranofin—psoriatic arthritis	0.000631	0.00679	CcSEcCtD
Rescinnamine—Endocrine disorder—Prednisone—psoriatic arthritis	0.000626	0.00672	CcSEcCtD
Rescinnamine—Dermatitis contact—Betamethasone—psoriatic arthritis	0.000589	0.00633	CcSEcCtD
Rescinnamine—Dermatitis contact—Dexamethasone—psoriatic arthritis	0.000589	0.00633	CcSEcCtD
Rescinnamine—Herpes zoster—Methotrexate—psoriatic arthritis	0.000576	0.00619	CcSEcCtD
Rescinnamine—Pruritus—Auranofin—psoriatic arthritis	0.000565	0.00607	CcSEcCtD
Rescinnamine—Injury—Prednisolone—psoriatic arthritis	0.000564	0.00606	CcSEcCtD
Rescinnamine—Gingivitis—Methotrexate—psoriatic arthritis	0.000552	0.00594	CcSEcCtD
Rescinnamine—Abscess—Methotrexate—psoriatic arthritis	0.000548	0.00589	CcSEcCtD
Rescinnamine—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.000542	0.00583	CcSEcCtD
Rescinnamine—Injury—Triamcinolone—psoriatic arthritis	0.000518	0.00557	CcSEcCtD
Rescinnamine—Injury—Methylprednisolone—psoriatic arthritis	0.000517	0.00556	CcSEcCtD
Rescinnamine—Rash—Auranofin—psoriatic arthritis	0.000504	0.00541	CcSEcCtD
Rescinnamine—Dermatitis—Auranofin—psoriatic arthritis	0.000503	0.00541	CcSEcCtD
Rescinnamine—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.000499	0.00536	CcSEcCtD
Rescinnamine—Skin discolouration—Methotrexate—psoriatic arthritis	0.00048	0.00516	CcSEcCtD
Rescinnamine—Nausea—Auranofin—psoriatic arthritis	0.000474	0.0051	CcSEcCtD
Rescinnamine—Injury—Dexamethasone—psoriatic arthritis	0.00047	0.00506	CcSEcCtD
Rescinnamine—Injury—Betamethasone—psoriatic arthritis	0.00047	0.00506	CcSEcCtD
Rescinnamine—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.000452	0.00486	CcSEcCtD
Rescinnamine—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.000452	0.00486	CcSEcCtD
Rescinnamine—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.000433	0.00466	CcSEcCtD
Rescinnamine—Influenza—Triamcinolone—psoriatic arthritis	0.000412	0.00443	CcSEcCtD
Rescinnamine—Injury—Prednisone—psoriatic arthritis	0.00041	0.0044	CcSEcCtD
Rescinnamine—Vaginal infection—Methotrexate—psoriatic arthritis	0.000409	0.0044	CcSEcCtD
Rescinnamine—Bronchitis—Triamcinolone—psoriatic arthritis	0.000396	0.00426	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000394	0.00423	CcSEcCtD
Rescinnamine—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000391	0.00421	CcSEcCtD
Rescinnamine—Conjunctivitis—Prednisolone—psoriatic arthritis	0.000388	0.00417	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000362	0.00389	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000361	0.00388	CcSEcCtD
Rescinnamine—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00036	0.00387	CcSEcCtD
Rescinnamine—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000359	0.00386	CcSEcCtD
Rescinnamine—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.000357	0.00384	CcSEcCtD
Rescinnamine—Rhinitis—Triamcinolone—psoriatic arthritis	0.00033	0.00355	CcSEcCtD
Rescinnamine—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00033	0.00354	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000328	0.00353	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000328	0.00353	CcSEcCtD
Rescinnamine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000327	0.00352	CcSEcCtD
Rescinnamine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000327	0.00351	CcSEcCtD
Rescinnamine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000327	0.00351	CcSEcCtD
Rescinnamine—Conjunctivitis—Betamethasone—psoriatic arthritis	0.000324	0.00348	CcSEcCtD
Rescinnamine—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.000324	0.00348	CcSEcCtD
Rescinnamine—Erythema—Prednisolone—psoriatic arthritis	0.000312	0.00335	CcSEcCtD
Rescinnamine—Erythema—Triamcinolone—psoriatic arthritis	0.000287	0.00308	CcSEcCtD
Rescinnamine—Erythema—Methylprednisolone—psoriatic arthritis	0.000286	0.00308	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000286	0.00307	CcSEcCtD
Rescinnamine—Myocardial infarction—Prednisone—psoriatic arthritis	0.000284	0.00306	CcSEcCtD
Rescinnamine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000281	0.00302	CcSEcCtD
Rescinnamine—Back pain—Triamcinolone—psoriatic arthritis	0.000278	0.00298	CcSEcCtD
Rescinnamine—Hypertension—Prednisolone—psoriatic arthritis	0.000269	0.0029	CcSEcCtD
Rescinnamine—Discomfort—Prednisolone—psoriatic arthritis	0.000262	0.00282	CcSEcCtD
Rescinnamine—Erythema—Dexamethasone—psoriatic arthritis	0.00026	0.0028	CcSEcCtD
Rescinnamine—Erythema—Betamethasone—psoriatic arthritis	0.00026	0.0028	CcSEcCtD
Rescinnamine—Oedema—Prednisolone—psoriatic arthritis	0.000255	0.00274	CcSEcCtD
Rescinnamine—Cough—Triamcinolone—psoriatic arthritis	0.00025	0.00269	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000248	0.00267	CcSEcCtD
Rescinnamine—Hypertension—Triamcinolone—psoriatic arthritis	0.000248	0.00266	CcSEcCtD
Rescinnamine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000247	0.00266	CcSEcCtD
Rescinnamine—Myalgia—Triamcinolone—psoriatic arthritis	0.000244	0.00263	CcSEcCtD
Rescinnamine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000244	0.00262	CcSEcCtD
Rescinnamine—Discomfort—Triamcinolone—psoriatic arthritis	0.000241	0.00259	CcSEcCtD
Rescinnamine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000241	0.00259	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000236	0.00253	CcSEcCtD
Rescinnamine—Oedema—Triamcinolone—psoriatic arthritis	0.000234	0.00252	CcSEcCtD
Rescinnamine—Infection—Triamcinolone—psoriatic arthritis	0.000233	0.0025	CcSEcCtD
Rescinnamine—Infection—Methylprednisolone—psoriatic arthritis	0.000232	0.00249	CcSEcCtD
Rescinnamine—Insomnia—Prednisolone—psoriatic arthritis	0.00023	0.00248	CcSEcCtD
Rescinnamine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000229	0.00246	CcSEcCtD
Rescinnamine—Erythema—Prednisone—psoriatic arthritis	0.000227	0.00244	CcSEcCtD
Rescinnamine—Hypertension—Dexamethasone—psoriatic arthritis	0.000225	0.00242	CcSEcCtD
Rescinnamine—Hypertension—Betamethasone—psoriatic arthritis	0.000225	0.00242	CcSEcCtD
Rescinnamine—Myalgia—Dexamethasone—psoriatic arthritis	0.000222	0.00238	CcSEcCtD
Rescinnamine—Myalgia—Betamethasone—psoriatic arthritis	0.000222	0.00238	CcSEcCtD
Rescinnamine—Discomfort—Betamethasone—psoriatic arthritis	0.000219	0.00235	CcSEcCtD
Rescinnamine—Discomfort—Dexamethasone—psoriatic arthritis	0.000219	0.00235	CcSEcCtD
Rescinnamine—Pain—Prednisolone—psoriatic arthritis	0.000218	0.00234	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000216	0.00232	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000213	0.00229	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000213	0.00229	CcSEcCtD
Rescinnamine—Oedema—Dexamethasone—psoriatic arthritis	0.000212	0.00228	CcSEcCtD
Rescinnamine—Oedema—Betamethasone—psoriatic arthritis	0.000212	0.00228	CcSEcCtD
Rescinnamine—Insomnia—Triamcinolone—psoriatic arthritis	0.000212	0.00228	CcSEcCtD
Rescinnamine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000211	0.00227	CcSEcCtD
Rescinnamine—Infection—Betamethasone—psoriatic arthritis	0.000211	0.00227	CcSEcCtD
Rescinnamine—Infection—Dexamethasone—psoriatic arthritis	0.000211	0.00227	CcSEcCtD
Rescinnamine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00021	0.00226	CcSEcCtD
Rescinnamine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00021	0.00225	CcSEcCtD
Rescinnamine—Urticaria—Prednisolone—psoriatic arthritis	0.000202	0.00217	CcSEcCtD
Rescinnamine—Pain—Triamcinolone—psoriatic arthritis	0.0002	0.00215	CcSEcCtD
Rescinnamine—Hypertension—Prednisone—psoriatic arthritis	0.000196	0.0021	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000194	0.00208	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000194	0.00208	CcSEcCtD
Rescinnamine—Myalgia—Prednisone—psoriatic arthritis	0.000193	0.00207	CcSEcCtD
Rescinnamine—Insomnia—Betamethasone—psoriatic arthritis	0.000192	0.00207	CcSEcCtD
Rescinnamine—Insomnia—Dexamethasone—psoriatic arthritis	0.000192	0.00207	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000191	0.00205	CcSEcCtD
Rescinnamine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000191	0.00205	CcSEcCtD
Rescinnamine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000191	0.00205	CcSEcCtD
Rescinnamine—Discomfort—Prednisone—psoriatic arthritis	0.000191	0.00205	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—psoriatic arthritis	0.000189	0.00204	CcSEcCtD
Rescinnamine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000188	0.00202	CcSEcCtD
Rescinnamine—Urticaria—Triamcinolone—psoriatic arthritis	0.000186	0.002	CcSEcCtD
Rescinnamine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000186	0.00199	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000186	0.00199	CcSEcCtD
Rescinnamine—Oedema—Prednisone—psoriatic arthritis	0.000185	0.00199	CcSEcCtD
Rescinnamine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000185	0.00199	CcSEcCtD
Rescinnamine—Infection—Prednisone—psoriatic arthritis	0.000184	0.00198	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—psoriatic arthritis	0.000183	0.00197	CcSEcCtD
Rescinnamine—Pain—Dexamethasone—psoriatic arthritis	0.000182	0.00195	CcSEcCtD
Rescinnamine—Pain—Betamethasone—psoriatic arthritis	0.000182	0.00195	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000174	0.00187	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000174	0.00187	CcSEcCtD
Rescinnamine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000173	0.00185	CcSEcCtD
Rescinnamine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000172	0.00185	CcSEcCtD
Rescinnamine—Urticaria—Dexamethasone—psoriatic arthritis	0.000169	0.00181	CcSEcCtD
Rescinnamine—Urticaria—Betamethasone—psoriatic arthritis	0.000169	0.00181	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000169	0.00181	CcSEcCtD
Rescinnamine—Dizziness—Prednisolone—psoriatic arthritis	0.000168	0.00181	CcSEcCtD
Rescinnamine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000168	0.00181	CcSEcCtD
Rescinnamine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000168	0.00181	CcSEcCtD
Rescinnamine—Insomnia—Prednisone—psoriatic arthritis	0.000167	0.0018	CcSEcCtD
Rescinnamine—Paraesthesia—Prednisone—psoriatic arthritis	0.000166	0.00179	CcSEcCtD
Rescinnamine—Pruritus—Triamcinolone—psoriatic arthritis	0.000166	0.00178	CcSEcCtD
Rescinnamine—Cough—Methotrexate—psoriatic arthritis	0.000165	0.00178	CcSEcCtD
Rescinnamine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000165	0.00178	CcSEcCtD
Rescinnamine—Myalgia—Methotrexate—psoriatic arthritis	0.000161	0.00173	CcSEcCtD
Rescinnamine—Rash—Prednisolone—psoriatic arthritis	0.000161	0.00173	CcSEcCtD
Rescinnamine—Dermatitis—Prednisolone—psoriatic arthritis	0.00016	0.00172	CcSEcCtD
Rescinnamine—Headache—Prednisolone—psoriatic arthritis	0.00016	0.00171	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—psoriatic arthritis	0.000159	0.00171	CcSEcCtD
Rescinnamine—Constipation—Prednisone—psoriatic arthritis	0.000158	0.0017	CcSEcCtD
Rescinnamine—Dizziness—Triamcinolone—psoriatic arthritis	0.000155	0.00166	CcSEcCtD
Rescinnamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000155	0.00166	CcSEcCtD
Rescinnamine—Infection—Methotrexate—psoriatic arthritis	0.000154	0.00165	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000151	0.00163	CcSEcCtD
Rescinnamine—Nausea—Prednisolone—psoriatic arthritis	0.000151	0.00163	CcSEcCtD
Rescinnamine—Pruritus—Dexamethasone—psoriatic arthritis	0.00015	0.00162	CcSEcCtD
Rescinnamine—Pruritus—Betamethasone—psoriatic arthritis	0.00015	0.00162	CcSEcCtD
Rescinnamine—Rash—Triamcinolone—psoriatic arthritis	0.000148	0.00159	CcSEcCtD
Rescinnamine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000148	0.00159	CcSEcCtD
Rescinnamine—Rash—Methylprednisolone—psoriatic arthritis	0.000147	0.00158	CcSEcCtD
Rescinnamine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000147	0.00158	CcSEcCtD
Rescinnamine—Urticaria—Prednisone—psoriatic arthritis	0.000147	0.00158	CcSEcCtD
Rescinnamine—Headache—Triamcinolone—psoriatic arthritis	0.000147	0.00158	CcSEcCtD
Rescinnamine—Headache—Methylprednisolone—psoriatic arthritis	0.000146	0.00157	CcSEcCtD
Rescinnamine—Abdominal pain—Prednisone—psoriatic arthritis	0.000146	0.00157	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000141	0.00151	CcSEcCtD
Rescinnamine—Dizziness—Betamethasone—psoriatic arthritis	0.000141	0.00151	CcSEcCtD
Rescinnamine—Dizziness—Dexamethasone—psoriatic arthritis	0.000141	0.00151	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—psoriatic arthritis	0.00014	0.0015	CcSEcCtD
Rescinnamine—Nausea—Triamcinolone—psoriatic arthritis	0.000139	0.00149	CcSEcCtD
Rescinnamine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000139	0.00149	CcSEcCtD
Rescinnamine—Nausea—Methylprednisolone—psoriatic arthritis	0.000139	0.00149	CcSEcCtD
Rescinnamine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000136	0.00147	CcSEcCtD
Rescinnamine—Rash—Dexamethasone—psoriatic arthritis	0.000134	0.00144	CcSEcCtD
Rescinnamine—Rash—Betamethasone—psoriatic arthritis	0.000134	0.00144	CcSEcCtD
Rescinnamine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000134	0.00144	CcSEcCtD
Rescinnamine—Dermatitis—Betamethasone—psoriatic arthritis	0.000134	0.00144	CcSEcCtD
Rescinnamine—Headache—Dexamethasone—psoriatic arthritis	0.000133	0.00143	CcSEcCtD
Rescinnamine—Headache—Betamethasone—psoriatic arthritis	0.000133	0.00143	CcSEcCtD
Rescinnamine—Pain—Methotrexate—psoriatic arthritis	0.000132	0.00142	CcSEcCtD
Rescinnamine—Pruritus—Prednisone—psoriatic arthritis	0.000131	0.00141	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000126	0.00136	CcSEcCtD
Rescinnamine—Nausea—Dexamethasone—psoriatic arthritis	0.000126	0.00136	CcSEcCtD
Rescinnamine—Nausea—Betamethasone—psoriatic arthritis	0.000126	0.00136	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—psoriatic arthritis	0.000123	0.00132	CcSEcCtD
Rescinnamine—Dizziness—Prednisone—psoriatic arthritis	0.000122	0.00132	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000122	0.00131	CcSEcCtD
Rescinnamine—Rash—Prednisone—psoriatic arthritis	0.000117	0.00125	CcSEcCtD
Rescinnamine—Dermatitis—Prednisone—psoriatic arthritis	0.000117	0.00125	CcSEcCtD
Rescinnamine—Headache—Prednisone—psoriatic arthritis	0.000116	0.00125	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000114	0.00122	CcSEcCtD
Rescinnamine—Nausea—Prednisone—psoriatic arthritis	0.00011	0.00118	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—psoriatic arthritis	0.000109	0.00118	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—psoriatic arthritis	0.000102	0.0011	CcSEcCtD
Rescinnamine—Rash—Methotrexate—psoriatic arthritis	9.75e-05	0.00105	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—psoriatic arthritis	9.74e-05	0.00105	CcSEcCtD
Rescinnamine—Headache—Methotrexate—psoriatic arthritis	9.69e-05	0.00104	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—psoriatic arthritis	9.19e-05	0.000987	CcSEcCtD
